Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 453 - 457 (2003)
Published online: 3 March 2003; | doi:10.1038/nm838

Adult mouse astrocytes degrade amyloid-bold beta in vitro and in situ

Tony Wyss-Coray1, 2, John D. Loike3, Thomas C. Brionne2, Emily Lu3, Roman Anankov3, Fengrong Yan4, Samuel C. Silverstein3 & Jens Husemann3

1  Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California, USA

2  Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA

3  Department of Physiology and Cellular Biophysics, Columbia University, New York, New York, USA

4  Gladstone Institute of Neurological Disease, San Francisco, California, USA

Correspondence should be addressed to Jens Husemann jh577@columbia.edu
Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by excessive deposition of amyloid-beta (Abeta) peptides in the brain. One of the earliest neuropathological changes in AD is the accumulation of astrocytes at sites of Abeta deposition1, but the cause or significance of this cellular response is unclear. Here we show that cultured adult mouse astrocytes migrate in response to monocyte chemoattractant protein-1 (MCP-1), a chemokine present in AD lesions1, and cease migration upon interaction with immobilized Abeta1−42. We also show that astrocytes bind and degrade Abeta1−42. Astrocytes plated on Abeta-laden brain sections from a mouse model of AD associate with the Abeta deposits and reduce overall Abeta levels in these sections. Our results suggest a novel mechanism for the accumulation of astrocytes around Abeta deposits, indicate a direct role for astrocytes in degradation of Abeta and implicate deficits in astroglial clearance of Abeta in the pathogenesis of AD. Treatments that increase removal of Abeta by astrocytes may therefore be a critical mechanism to reduce the neurodegeneration associated with AD.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

RESEARCH
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice
Nature Medicine Article (01 May 2001)

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

  • Delayed Burst Release

    • Deadline: Mar 04 2010
    • Reward: $20,000 USD

    A mechanism is desired that will have little or no release until triggered and then substantially re...

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Jan 31 2010
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

naturejobs

Figures & Tables
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy